+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological Implants Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Biological Implants Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Biological Implants Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6011394
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Implants Market grew from USD 40.90 billion in 2024 to USD 49.91 billion in 2025. It is expected to continue growing at a CAGR of 21.42%, reaching USD 131.13 billion by 2030.

Navigating the Rise of Biological Implants: An Executive Overview

The field of biological implants has evolved from rudimentary grafts to sophisticated, tissue-engineered solutions that promise to redefine patient outcomes across multiple therapeutic areas. Rapid advancements in biotechnology, material science, and surgical techniques are fueling innovation, enabling implants that integrate seamlessly with native tissues to restore function, reduce rejection, and accelerate recovery. As the global healthcare landscape grapples with aging populations, rising chronic disease burdens, and intensifying demands for minimally invasive procedures, biological implants are poised to play a transformative role in addressing unmet clinical needs.

This executive summary provides a comprehensive overview of key developments shaping the biological implants market, examines critical shifts in regulatory and economic environments, and distills actionable insights for industry stakeholders. By unpacking the cumulative impact of newly implemented U.S. tariffs, dissecting market segmentation nuances, and highlighting regional and competitive dynamics, this document equips decision-makers with the strategic perspectives needed to capitalize on emerging opportunities and mitigate potential risks.

Transformative Shifts Reshaping the Biological Implants Landscape

The landscape of biological implants is undergoing transformative shifts driven by breakthroughs in regenerative medicine, adoption of advanced materials, and convergence with digital health technologies. Clinicians are increasingly leveraging collagen and fibrin scaffolds functionalized with growth factors to accelerate tissue repair, while biofabrication techniques-such as 3D bioprinting-are enabling patient-specific constructs for complex anatomical reconstructions. At the same time, the integration of sensors within implantable devices is giving rise to intelligent systems capable of real-time monitoring and remote management of patient conditions.

Regulatory agencies across North America and Europe are responding to these innovations by streamlining approval pathways for combination products, fostering public-private partnerships, and issuing adaptive guidelines that balance safety with accelerated patient access. Meanwhile, strategic collaborations between established medical device companies and biotech innovators are intensifying, as both seek to harness complementary expertise in upstream research and downstream commercialization. These converging dynamics are reshaping competitive landscapes, driving consolidation, and setting the stage for next-generation therapeutic platforms poised to redefine standards of care.

Analyzing the Cumulative Impact of U.S. Tariffs in 2025

In 2025, the United States implemented a series of tariffs targeting imported material components and finished biological implant products. These measures, designed to bolster domestic manufacturing and reduce dependency on foreign suppliers, have had a mixed impact on market players. On one hand, increased duties on collagen-based and fibrin-based scaffold imports have elevated production costs for smaller manufacturers, leading some to reevaluate their supply chain strategies.

Conversely, the tariffs have created opportunities for local producers of metallic primary supports such as titanium-based alloy frames and for emerging domestic facilities specializing in cell culture and bioprocessing. Larger multinational organizations with integrated manufacturing footprints have been better positioned to absorb the incremental costs through economies of scale. However, both domestic and international players are now exploring strategic adjustments-including nearshoring critical material production, entering long-term supplier agreements, and renegotiating distributor contracts-to mitigate margin compression and maintain competitive pricing for hospital systems and ambulatory surgical centers.

Dissecting Key Market Segmentation Insights

A nuanced understanding of market segmentation is essential for tailoring product development, regulatory submissions, and marketing strategies. Based on type, the landscape encompasses cardiovascular implants such as heart valves, pacemakers, and stents; cochlear implants differentiated by behind-the-ear and ear-level processors; cosmetic implants including breast and facial variants; dental implants spanning endosteal and subperiosteal designs; neurostimulators categorized into deep brain and spinal cord stimulators; ophthalmic implants covering corneal devices and intraocular lenses; and orthopedic implants segmented into joint replacements, spinal constructs, and trauma stabilization systems. Material segmentation highlights the use of biological scaffolds derived from collagen and fibrin, ceramic options like alumina and zirconia, metallic frameworks primarily composed of cobalt-chromium or titanium alloys, and polymeric matrices including polyethylene and polylactic acid.

From an application standpoint, products serve cardiovascular disorders such as coronary artery disease and arrhythmias, cosmetic enhancements involving body contouring and facial rejuvenation, dental procedures ranging from single tooth replacements to full dental bridges, neurological indications including chronic pain and Parkinson’s management, orthopedic interventions for hip and knee restoration, and reconstructive surgeries encompassing breast and limb restoration. End users span ambulatory surgical centers with dedicated cardiovascular and orthopedic units, hospitals split between private and public institutions, personal clinics specializing in cosmetic and dental treatments, and research institutes operating both academic laboratories and private R&D firms. Finally, the product life cycle stage varies across clinical trials (phases 1 through 3), post-launch monitoring activities focused on compliance testing and performance analytics, and upstream research and development stages covering conceptualization and prototype validation. This segmentation framework underscores the heterogeneity of market needs and the imperative for specialized value propositions at each intersection of type, material, application, end user, and life cycle stage.

Unpacking Key Regional Insights Across Americas, EMEA, and Asia-Pacific

Regional dynamics continue to shape investment priorities, regulatory approaches, and adoption rates for biological implants. In the Americas, robust reimbursement frameworks in the United States and Canada are accelerating uptake of high-cost advanced therapies, while Latin American markets are emerging as growth frontiers due to increasing healthcare infrastructure investments and public sector partnerships. Europe, the Middle East & Africa present a dichotomy of mature Western European markets pushing the boundaries of regenerative medicine through harmonized CE marking and innovative HTA methodologies, contrasted against GCC nations focused on localized manufacturing incentives and sub-Saharan regions building capacity through international aid programs. Meanwhile, Asia-Pacific is witnessing a surge in domestic implant production across China, Japan, South Korea, and India, fueled by government subsidies, rising R&D expenditures, and expanding domestic demand from aging populations. Each region exhibits distinct regulatory cadences, procurement models, and clinical adoption curves, necessitating tailored market entry and expansion strategies for global stakeholders.

Evaluating Key Company and Competitive Dynamics

The competitive landscape of biological implants is characterized by a blend of established conglomerates, specialized biotechs, and emerging disruptors. Major players such as AbbVie, Baxter International, and Johnson & Johnson leverage integrated pipelines spanning biologics and device platforms, while Medtronic and Stryker extend their leadership in cardiovascular and orthopedic implants through strategic acquisitions and in-house R&D. Companies like CryoLife and Integra LifeSciences focus on niche graft and scaffold technologies, whereas innovators such as Altogen Labs and Auto Tissue Berlin pioneer advanced cell-based therapies. Academic spinouts like BioPolymer GmbH & Co. KG and TissueTech drive novel biomaterial formulations, and surgical specialists including Alphatec Spine, NuVasive, and RTI Surgical refine application-specific solutions for neurosurgical and orthopedic interventions. Smaller firms such as Allografts.com, Citagenix, Surgenex, and Sanara MedTech collaborate with contract research organizations to advance clinical trial portfolios, while global giants like Edward LifeSciences, Conmed, KLS Martin, and Zimmer Biomet maintain diversified implant offerings across multiple therapeutic domains.

Actionable Recommendations for Industry Leadership

Industry leaders must adopt a multi-faceted strategy to capitalize on emerging opportunities while mitigating tariff pressures and competitive threats. First, strengthening vertically integrated supply chains by investing in local manufacturing capabilities for collagen and fibrin scaffolds can insulate operations from import duties and logistical disruptions. Second, forging collaborative alliances with digital health providers to incorporate sensor-enabled monitoring into implantable devices will enhance postoperative care and support outcome-based reimbursement models. Third, prioritizing pipeline diversification through modular product platforms that can be rapidly adapted across cardiovascular, orthopedic, and neurological applications will maximize R&D ROI and accelerate time to market. Fourth, engaging proactively with regulatory bodies to co-develop adaptive clinical trial designs and real-world evidence generation plans will secure smoother approval pathways and foster payer acceptance. Finally, tailoring go-to-market approaches with region-specific value propositions-leveraging public-private partnerships in EMEA and localized production incentives in Asia-Pacific-will optimize market penetration and long-term growth.

Concluding Perspectives on Strategic Imperatives

Biological implants stand at the intersection of regenerative medicine and advanced materials science, offering transformative potential for patient care across multiple specialties. Navigating this dynamic environment requires a clear understanding of segmentation intricacies, regulatory complexities, and evolving competitive forces. Companies that align integrated supply chains with digital innovation, prioritize diversified pipelines, and engage stakeholders through collaborative regulatory frameworks will be best positioned to capture value and drive sustainable growth.

Market Segmentation & Coverage

This research report categorizes the Biological Implants Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cardiovascular Implants
    • Heart Valves
    • Pacemakers
    • Stents
  • Cochlear Implants
    • Behind-the-Ear Processors
    • Ear-Level Processors
  • Cosmetic Implants
    • Breast Implants
    • Facial Implants
  • Dental Implants
    • Endosteal Implants
    • Subperiosteal Implants
  • Neurostimulators
    • Deep Brain Stimulators
    • Spinal Cord Stimulators
  • Ophthalmic Implants
    • Corneal Implants
    • Intraocular Lenses
  • Orthopedic Implants
    • Joint Replacements
    • Spinal Implants
    • Trauma Implants
  • Biological Implants
    • Collagen-Based Implants
    • Fibrin-Based Implants
  • Ceramic Implants
    • Alumina Implants
    • Zirconia Implants
  • Metallic Implants
    • Cobalt-Chromium Implants
    • Titanium Implants
  • Polymeric Implants
    • Polyethylene Implants
    • Polylactic Acid Implants
  • Cardiovascular Applications
    • Coronary Artery Disease
    • Heart Rhythm Disorders
  • Cosmetic Applications
    • Body Contouring
    • Facial Enhancement
  • Dental Applications
    • Full Dental Bridge
    • Single Tooth Replacement
  • Neurological Applications
    • Chronic Pain Management
    • Parkinson’s Disease
  • Orthopedic Applications
    • Hip Replacement
    • Knee Replacement
  • Reconstructive Surgery
    • Breast Reconstruction
    • Limb Reconstruction
  • Ambulatory Surgical Centers
    • Cardiovascular Centers
    • Orthopedic Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Personal Clinics
    • Cosmetic Clinics
    • Dental Clinics
  • Research Institutes
    • Academic Laboratories
    • Private Research Firms
  • Clinical Trials
    • Phase 1
    • Phase 2
    • Phase 3
  • Post-Launch Monitoring
    • Compliance Tests
    • Performance Analysis
  • Research & Development
    • Conceptualization
    • Prototyping

This research report categorizes the Biological Implants Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biological Implants Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • Allografts.com
  • Alphatec Spine, Inc.
  • Altogen Labs
  • Auto Tissue Berlin GmbH
  • Baxter International, Inc.
  • BioPolymer GmbH & Co. KG
  • Citagenix Inc.
  • Conmed Corporation
  • CryoLife, Inc.
  • Edward LifeSciences Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin, L.P. by Leibinger family
  • Medical Device Business Services, Inc.
  • Medtronic PLC
  • NuVasive, Inc. by Globus Medical Inc
  • RTI Surgical, Inc.
  • Sanara MedTech, Inc.
  • Stryker Corporation
  • Surgenex LLC
  • TissueTech, Inc.
  • Zimmer Biomet Holdings, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biological Implants Market, by Type
8.1. Introduction
8.2. Cardiovascular Implants
8.2.1. Heart Valves
8.2.2. Pacemakers
8.2.3. Stents
8.3. Cochlear Implants
8.3.1. Behind-the-Ear Processors
8.3.2. Ear-Level Processors
8.4. Cosmetic Implants
8.4.1. Breast Implants
8.4.2. Facial Implants
8.5. Dental Implants
8.5.1. Endosteal Implants
8.5.2. Subperiosteal Implants
8.6. Neurostimulators
8.6.1. Deep Brain Stimulators
8.6.2. Spinal Cord Stimulators
8.7. Ophthalmic Implants
8.7.1. Corneal Implants
8.7.2. Intraocular Lenses
8.8. Orthopedic Implants
8.8.1. Joint Replacements
8.8.2. Spinal Implants
8.8.3. Trauma Implants
9. Biological Implants Market, by Material
9.1. Introduction
9.2. Biological Implants
9.2.1. Collagen-Based Implants
9.2.2. Fibrin-Based Implants
9.3. Ceramic Implants
9.3.1. Alumina Implants
9.3.2. Zirconia Implants
9.4. Metallic Implants
9.4.1. Cobalt-Chromium Implants
9.4.2. Titanium Implants
9.5. Polymeric Implants
9.5.1. Polyethylene Implants
9.5.2. Polylactic Acid Implants
10. Biological Implants Market, by Application
10.1. Introduction
10.2. Cardiovascular Applications
10.2.1. Coronary Artery Disease
10.2.2. Heart Rhythm Disorders
10.3. Cosmetic Applications
10.3.1. Body Contouring
10.3.2. Facial Enhancement
10.4. Dental Applications
10.4.1. Full Dental Bridge
10.4.2. Single Tooth Replacement
10.5. Neurological Applications
10.5.1. Chronic Pain Management
10.5.2. Parkinson’s Disease
10.6. Orthopedic Applications
10.6.1. Hip Replacement
10.6.2. Knee Replacement
10.7. Reconstructive Surgery
10.7.1. Breast Reconstruction
10.7.2. Limb Reconstruction
11. Biological Implants Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Cardiovascular Centers
11.2.2. Orthopedic Centers
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Personal Clinics
11.4.1. Cosmetic Clinics
11.4.2. Dental Clinics
11.5. Research Institutes
11.5.1. Academic Laboratories
11.5.2. Private Research Firms
12. Biological Implants Market, by Product Life Cycle Stage
12.1. Introduction
12.2. Clinical Trials
12.2.1. Phase 1
12.2.2. Phase 2
12.2.3. Phase 3
12.3. Post-Launch Monitoring
12.3.1. Compliance Tests
12.3.2. Performance Analysis
12.4. Research & Development
12.4.1. Conceptualization
12.4.2. Prototyping
13. Americas Biological Implants Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Biological Implants Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Biological Implants Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Allografts.com
16.3.3. Alphatec Spine, Inc.
16.3.4. Altogen Labs
16.3.5. Auto Tissue Berlin GmbH
16.3.6. Baxter International, Inc.
16.3.7. BioPolymer GmbH & Co. KG
16.3.8. Citagenix Inc.
16.3.9. Conmed Corporation
16.3.10. CryoLife, Inc.
16.3.11. Edward LifeSciences Corporation
16.3.12. Integra LifeSciences Corporation
16.3.13. Johnson & Johnson Services, Inc.
16.3.14. KLS Martin, L.P. by Leibinger family
16.3.15. Medical Device Business Services, Inc.
16.3.16. Medtronic PLC
16.3.17. NuVasive, Inc. by Globus Medical Inc
16.3.18. RTI Surgical, Inc.
16.3.19. Sanara MedTech, Inc.
16.3.20. Stryker Corporation
16.3.21. Surgenex LLC
16.3.22. TissueTech, Inc.
16.3.23. Zimmer Biomet Holdings, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOLOGICAL IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. BIOLOGICAL IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOLOGICAL IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BEHIND-THE-EAR PROCESSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY EAR-LEVEL PROCESSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BREAST IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY FACIAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ENDOSTEAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CORNEAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TRAUMA IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COLLAGEN-BASED IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY FIBRIN-BASED IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ALUMINA IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ZIRCONIA IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COBALT-CHROMIUM IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TITANIUM IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYETHYLENE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYLACTIC ACID IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HEART RHYTHM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BODY CONTOURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY FACIAL ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY FULL DENTAL BRIDGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SINGLE TOOTH REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY LIMB RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRIVATE RESEARCH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COMPLIANCE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PERFORMANCE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CONCEPTUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PROTOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 198. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 200. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 201. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 202. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 203. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 204. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 205. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 206. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 208. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 209. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 210. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 211. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 213. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 214. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 215. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 216. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 217. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 218. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 220. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 222. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 223. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 224. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 225. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 226. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 227. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 229. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 230. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 231. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 232. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 233. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 234. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 235. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 236. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 237. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 238. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 239. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 240. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 242. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 243. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 244. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 245. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 247. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 249. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 251. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 252. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 253. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 254. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 255. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 264. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 265. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 266. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 267. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 268. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 269. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 271. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 272. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 273. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 274. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 275. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 276. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 278. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 279. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 280. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 281. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 282. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 283. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 284. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 285. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 286. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 288. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 290. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY BIOLOGICAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY CERAMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY METALLIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY POLYMERIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PERSONAL CLINICS, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT LIFE CYCLE STAGE, 2018-2030 (USD MILLION)
TABLE 312. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY POST-LAUNCH MONITORING, 2018-2030 (USD MILLION)
TABLE 314. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 315. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 316. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 318. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY COCHLEAR IMPLANTS, 2018-2030 (USD MILLION)
TABLE 319. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 320. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 321. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY NEUROSTIMULATORS, 2018-2030 (USD MILLION)
TABLE 322. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 323. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2030 (USD MILLION)
TABLE 324. AUSTRALIA BIOLOG

Companies Mentioned

  • AbbVie Inc.
  • Allografts.com
  • Alphatec Spine, Inc.
  • Altogen Labs
  • Auto Tissue Berlin GmbH
  • Baxter International, Inc.
  • BioPolymer GmbH & Co. KG
  • Citagenix Inc.
  • Conmed Corporation
  • CryoLife, Inc.
  • Edward LifeSciences Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin, L.P. by Leibinger family
  • Medical Device Business Services, Inc.
  • Medtronic PLC
  • NuVasive, Inc. by Globus Medical Inc
  • RTI Surgical, Inc.
  • Sanara MedTech, Inc.
  • Stryker Corporation
  • Surgenex LLC
  • TissueTech, Inc.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Bio-Implants Market Size, Share, Trends and Forecast by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region, 2025-2033 - Product Image

Bio-Implants Market Size, Share, Trends and Forecast by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region, 2025-2033

  • Report
  • 133 Pages
  • Global
From
Biological Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Biological Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 186 Pages
  • Global
From
Bio-Implants Market Report 2025 - Product Image

Bio-Implants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bio Implants Market Report and Forecast 2024-2032 - Product Image

Bio Implants Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Bioimplants - Global Strategic Business Report - Product Image

Bioimplants - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.